• Nanoplastics and Cadmium Co-exposure Triggers Intestinal Apo

  2026-05-25

  This study demonstrates that co-exposure to polystyrene nanoplastics (PS-NPs) and cadmium (Cd) synergistically induces apoptosis in intestinal cells by activating the IP3R/Ca2+/STAT3 signaling axis. The findings provide molecular-level insight into environmental risk, and establish calcium chelation as a critical tool for dissecting pathway mechanisms in toxicology research.

• Afatinib in Complex Tumor Microenvironment Modeling for Rese

  2026-05-25

  Explore how Afatinib (BIBW 2992) advances cancer biology research by enabling nuanced dissection of EGFR, HER2, and HER4 signaling in physiologically relevant microenvironments. This article offers a deep dive into its applications in advanced assembloid models and practical protocol guidance.

• APOC1 Drives Thyroid Carcinoma Progression and Sensitizes to

  2026-05-24

  This study identifies Apolipoprotein C1 (APOC1) as a critical driver of papillary thyroid carcinoma (PTC) progression and immune evasion. By integrating transcriptomic analysis and functional assays, the authors show that targeting APOC1 enhances the anti-tumor efficacy of the Hedgehog signaling inhibitor cyclopamine, supporting APOC1 as a promising molecular target for PTC therapy.

• Ambroxol Modulates Nav1.8, TRPV1, and TRPA1 in Neuropathic P

  2026-05-23

  This article examines a recent study that dissects how ambroxol, traditionally a secretolytic, directly modulates human Nav1.8 sodium channels, TRPV1, and TRPA1 receptors in the context of topical neuropathic pain treatment. The findings clarify ambroxol’s ion channel selectivity, its interaction with capsaicin-induced TRPV1 signaling, and the mechanistic implications for designing targeted topical analgesics.

• Advancing In Vitro Drug Response Evaluation in Cancer Resear

  2026-05-22

  Schwartz’s dissertation introduces a refined approach to measuring drug responses in cancer cell cultures by distinguishing between proliferative arrest and cell death. This methodological innovation provides greater clarity in interpreting anti-cancer compound efficacy, offering practical implications for compound screening and mechanistic studies.

• EPZ-6438 (SKU A8221): Advancing EZH2 Inhibitor Assays in Can

  2026-05-22

  This article provides a scenario-driven, evidence-based guide for deploying EPZ-6438 (SKU A8221) as a highly selective EZH2 inhibitor in epigenetic cancer research workflows. Drawing on peer-reviewed data and practical laboratory challenges, it highlights how EPZ-6438 ensures reliable, reproducible results across cell viability and cytotoxicity assays. The guide is grounded in best practices for bench scientists and includes actionable protocol parameters and vendor selection insights.

• PPT (Propyl Pyrazole Triol): Redefining ERα-Selective Resear

  2026-05-21

  Explore how PPT (Propyl Pyrazole Triol), a potent ERα agonist, enables next-generation estrogen receptor signaling research. This article uncovers novel experimental strategies and practical assay design, offering fresh insights beyond current literature.

• DMH1 ALK2 Inhibitor: Optimizing Organoid and NSCLC Workflows

  2026-05-21

  DMH-1 unlocks precise BMP pathway modulation for advanced organoid engineering and non-small cell lung cancer research. Discover how this selective ALK2 inhibitor, supplied by APExBIO, accelerates reproducibility, cellular diversity, and translational potential in high-impact experimental models.

• DAPI (hydrochloride): Protocols and QC for DNA Visualization

  2026-05-20

  DAPI (hydrochloride) offers a reliable, high-affinity DNA-specific fluorescent stain for cell cycle analysis, chromosome staining, and DNA visualization in histochemistry. It excels in applications with fixed and live cells but requires protocol adjustments for low-permeability live-cell assays. Not optimal for ethanol-based workflows or where RNA selectivity is critical.

• Sulfo-Cy5 Carboxylic Acid: Precision Fluorescent Dye for Lif

  2026-05-20

  Sulfo-Cy5 carboxylic acid sets a new benchmark for hydrophilic fluorescent labeling in protein, peptide, and advanced immunological research, enabling high-sensitivity detection in fully aqueous workflows. Its unmatched water solubility and minimized fluorescence quenching make it a superior choice for reproducible fluorescence imaging and real-time biologic tracking.

• DiscoveryProbe FDA-approved Drug Library: Applied Workflows

  2026-05-19

  The DiscoveryProbe FDA-approved Drug Library (SKU: L1021) empowers translational researchers to rapidly identify novel indications and mechanisms using clinically relevant compounds. Integrating this FDA-approved bioactive compound library with tailored experimental workflows accelerates drug repositioning, target identification, and screening in oncology and neurodegenerative disease models.

• Refining In Vitro Drug Response Evaluation in Cancer Researc

  2026-05-19

  Schwartz's dissertation introduces a refined framework for evaluating anti-cancer drugs in vitro by differentiating between proliferative arrest and cell death. This approach clarifies drug action mechanisms, enabling more precise preclinical assessments and improving translational relevance for cancer biology research.

• Dual Glutamate Receptor Blockade Counters Soman-Induced Neur

  2026-05-18

  The reference study demonstrates that dual antagonism of AMPA and NMDA receptors with IEM-1925 robustly suppresses status epilepticus, limits neurodegeneration, and improves cognition following soman exposure in rats. These findings highlight a mechanistically targeted approach for neuroprotection in organophosphate poisoning models, informing both excitotoxicity research and translational assay design.

• Structure-Based Discovery of NSP15 Inhibitors for SARS-CoV-2

  2026-05-18

  This paper presents a structure-based virtual screening of natural products against the SARS-CoV-2 NSP15 endoribonuclease, identifying thymopentin and oleuropein as potent inhibitors. The findings demonstrate the therapeutic potential of targeting NSP15 in viral immune evasion and offer a methodological template for rational inhibitor discovery.

• Transmission Dynamics of Carbapenemase Genes in CREC in Guan

  2026-05-17

  This study systematically characterizes the distribution and transferability of carbapenemase-encoding genes (CEGs) in carbapenem-resistant Enterobacter cloacae (CREC) collected from eight hospitals in Guangdong, China, during the COVID-19 era. The findings highlight high prevalence, multidrug resistance, and efficient horizontal gene transfer of CEGs, informing infection control strategies and future research on Gram-negative bacterial resistance.

466 records 18/32 page Previous Next First page 上5页 1617181920 下5页 Last page